Cardinal Health Exceeds Q4 Estimates, Raises 2025 Profit Outlook

Strong pharmaceutical sales drive revenue growth and improved earnings forecasts for the healthcare firm.

Cardinal Health reported Q4 adjusted earnings per share of $1.84, surpassing analyst expectations.
Revenue for the quarter increased by 12% year-over-year to $59.9 billion.
The company raised its full-year adjusted EPS guidance to a range of $7.55 to $7.70 for fiscal 2025.
Pharmaceutical and Specialty Solutions unit sales rose 13% to $55.6 billion in Q4.
Cardinal Health plans to increase share repurchases to $750 million in fiscal 2025.